Peptide inhibitors of Hepatitis C virus NS3 protein
US6846806B2 · kind B2 · utility
58Cited by
0References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 23, 2001 |
| Grant date | Jan 25, 2005 |
| Priority date | — |
| Expiry date | Nov 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a novel class of peptides having the Formula (I): which are useful as serine protease inhibitors, and more particularly as Hepatitis C virus(HCV) NS3 protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same in the treatment of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.